Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (JPRN-jRCT2051250126) titled 'A Study of Orforglipron (LY3502970) in Participants With Obesity or Overweight and Osteoarthritis (OA) of the Knee' on Oct. 3.
Study Type: Interventional
Study Design:
randomized controlled trial, single blind, placebo control, parallel assignment, treatment purpose
Primary Sponsor: Masaki Takeshi
Condition:
Osteoarthritis
Intervention:
DRUG: Orforglipron(Other Name: (LY3502970))
Administered orally
DRUG: Placebo
Administered orally
(Study Arms)
Experimental: Orforglipron (GZT1)
Participants will receive orforglipron orally
Interventions:
Drug: Orforglipron
Placebo Comparator: Placebo (GZT1...